Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

Podobne knjige/članki

• Deferasirox for managing iron overload in people with myelodysplastic syndrome
  od: Meerpohl, Joerg J, et al.
  Izdano: (2014)
• Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome
  od: Shenoy, Niraj, et al.
  Izdano: (2014)
• Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease
  od: Cerchione, Claudio, et al.
  Izdano: (2018)
• Deferasirox, an oral chelator in the treatment of iron overload
  od: I. Portioli
  Izdano: (2013-05-01)
• Update on the use of deferasirox in the management of iron overload
  od: Taher, Ali, et al.
  Izdano: (2009)